Rheumatoid arthritis Trials in Victoria, Canada
Conditions / Rheumatoid arthritis / Victoria, Canada
Clinical trials for Rheumatoid arthritis investigate a range of treatment strategies and patient populations.
24 total trials for this combination
Showing top 10 of 24 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01709578 | To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET) | COMPLETED | PHASE3 |
| NCT01146652 | Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND) | COMPLETED | PHASE3 |
| NCT01242514 | Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA) | TERMINATED | PHASE3 |
| NCT01721057 | A Study in Moderate to Severe Rheumatoid Arthritis Participants | COMPLETED | PHASE3 |
| NCT01885078 | An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT01331837 | A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors | COMPLETED | PHASE4 |
| NCT01710358 | A Study in Moderate to Severe Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT00420927 | Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis | COMPLETED | PHASE4 |
| NCT00720798 | An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies | COMPLETED | PHASE3 |
| NCT01711359 | A Study in Participants With Moderate to Severe Rheumatoid Arthritis | COMPLETED | PHASE3 |